Sun Pharma Advanced Research Company Ltd

NSE: SPARC BSE: 532872

₹114.89

(-4.96%)

Wed, 01 Apr 2026, 11:59 am

MTF 5xInvest in Sun Pharma Advanced Research Company Ltd with 5x Leverage Buy with MTF

Market Cap37.19B

PE Ratio0

Dividend0

Health Technology

Pharmaceuticals: Major

24.5K

Sun Pharma Advanced Research Company EV/EBITDA Ratio

D/E EV EV/EBITDA P/B P/CF P/E P/S ROE %

Particulars	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Price to earnings ratio	0	0	0	0	0	0	113.91	0	0	0	0	0	0	0	0	0	0	0
Price to book ratio	38.86	30.51	146.12	265.18	0	24.82	24.77	116.67	227.92	49.44	51.40	16.98	0	0	258.46	11.36	95.47	0
Price to sales ratio	44.71	30.97	60.02	25.56	53.36	28.39	20.66	74.76	42.26	43.07	119.94	26.84	32.92	14.68	56.91	21.40	158.92	66.92
Price to cash flow ratio	0	43.05	164.25	538.66	0	0	114.37	0	0	0	0	0	0	0	0	0	0	0
Enterprise value	16.75B	10.9B	20.62B	14.93B	16.08B	24.55B	34.43B	116.29B	68.58B	77.19B	92.8B	46.98B	25.88B	39.34B	78.78B	47.22B	119.1B	50.7B
Enterprise value to EBITDA ratio	81.59	0	0	0	0	0	101.89	0	0	0	0	0	0	0	0	0	0	0
Debt to equity ratio	0.01	0.05	0.15	1.17	0	0.75	0.04	0.04	1.86	0.02	0.01	0.01	0	0	2.54	0.03	0.49	0
Return on equity %	-10.33	-22.71	-86.56	-86.09	0	-107.55	24.48	-33.06	-107.93	-126.60	-114.41	-60.48	-225.08	0	0	-81.83	-121.28	0

Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio

The Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Sun Pharma Advanced Research Company Ltd's valuation, profitability, and overall financial performance. Tracking the Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Sun Pharma Advanced Research Company Ltd (NSE: SPARC, BSE: 532872) is currently trading at ₹114.89, with a market capitalization of ₹37.19B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.

Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio Current Value

The current Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio stands at 0.

The Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio remains stable, indicating consistent financial performance.

Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio Historical Trend

The Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:

2024: 0
2023: 0
2022: 0
2021: 0
2020: 0

The decline in Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.

What Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio Indicates for Investors

The Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Sun Pharma Advanced Research Company Ltd.

Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio Analysis Summary

The Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Sun Pharma Advanced Research Company Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800